{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:13:25Z","timestamp":1787616805789,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.ppat.1010859","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000}}],"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>The majority of adenovirus (Ad) vectors are based on human Ad type 5, which is a member of Ad species C. Species C also includes the closely-related types 1, 2, 6, 57 and 89. It is known that coagulation factors bind to Ad5 hexon and play a key role in the liver tropism of Ad5 vectors, but it is unclear how coagulation factors affect vectors derived from other species C Ads. We evaluated species C Ad vectors both in vitro and following intravenous injection in mice. To assess the impact of hexon differences, we constructed chimeric Ad5 vectors that contain the hexon hypervariable regions from other species C types, including vectors with hexon mutations that decreased coagulation factor binding. After intravenous injection into mice, vectors with Ad5 or Ad6 hexon had strong liver tropism, while vectors with chimeric hexon from other Ad types had weaker liver tropism due to inhibition by natural antibodies and complement. In addition, we discovered a novel ability of hexon to bind prothrombin, which is the most abundant coagulation factor in blood, and we found striking differences in the affinity of Ads for human, mouse and bovine coagulation factors. When compared to Ad5, vectors with non-Ad5 species C hexons had considerably higher affinity for both human and mouse prothrombin. Most of the vectors tested were strongly dependent on coagulation factors for liver transduction, but vectors with chimeric Ad6 hexon showed much less dependence on coagulation factors than other vectors. We found that in vitro neutralization experiments with mouse serum predicted in vivo behavior of Ad5 vectors, but in vitro experiments did not predict the in vivo behavior of vectors based on other Ad types. In sum, hexons from different human Ad species C viruses confer diverse properties on vectors, including differing abilities to target the liver.<\/jats:p>","DOI":"10.1371\/journal.ppat.1010859","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T17:48:29Z","timestamp":1664214509000},"page":"e1010859","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo"],"prefix":"10.1371","volume":"18","author":[{"given":"Jie","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Moitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-2629","authenticated-orcid":true,"given":"Andrew P.","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"issue":"3","key":"ppat.1010859.ref001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"SN Waddington","year":"2008","journal-title":"Cell"},{"issue":"1","key":"ppat.1010859.ref002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2010.10.041","article-title":"Characterization of species C human adenovirus serotype 6 (Ad6)","volume":"412","author":"EA Weaver","year":"2011","journal-title":"Virology"},{"issue":"2","key":"ppat.1010859.ref003","doi-asserted-by":"crossref","first-page":"e1004673","DOI":"10.1371\/journal.ppat.1004673","article-title":"Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo","volume":"11","author":"J Ma","year":"2015","journal-title":"PLoS Pathog"},{"key":"ppat.1010859.ref004","article-title":"Interaction of adenovirus with antibodies, complement, and coagulation factors","author":"RJ Allen","year":"2019","journal-title":"FEBS Lett"},{"issue":"14","key":"ppat.1010859.ref005","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.0711757105","article-title":"Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo","volume":"105","author":"O Kalyuzhniy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"ppat.1010859.ref006","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Z Xu","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"ppat.1010859.ref007","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Z Xu","year":"2013","journal-title":"Nat Med"},{"issue":"6","key":"ppat.1010859.ref008","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1128\/JVI.03217-14","article-title":"Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors","volume":"89","author":"Q Qiu","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"ppat.1010859.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/v11070616","article-title":"Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo","volume":"11","author":"A Doszpoly","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"ppat.1010859.ref010","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1128\/jvi.70.3.1836-1844.1996","article-title":"Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues","volume":"70","author":"L Crawford-Miksza","year":"1996","journal-title":"J Virol"},{"issue":"6108","key":"ppat.1010859.ref011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1226625","article-title":"Coagulation factor X activates innate immunity to human species C adenovirus","volume":"338","author":"K Doronin","year":"2012","journal-title":"Science"},{"issue":"5","key":"ppat.1010859.ref012","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"R Alba","year":"2009","journal-title":"Blood"},{"issue":"2","key":"ppat.1010859.ref013","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/10430340252769824","article-title":"Hexon gene switch strategy for the generation of chimeric recombinant adenovirus","volume":"13","author":"R Youil","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"12","key":"ppat.1010859.ref014","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1128\/JVI.72.12.10260-10264.1998","article-title":"Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype","volume":"72","author":"JG Gall","year":"1998","journal-title":"J Virol"},{"issue":"7090","key":"ppat.1010859.ref015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"DM Roberts","year":"2006","journal-title":"Nature"},{"issue":"2","key":"ppat.1010859.ref016","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"RR Bradley","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"ppat.1010859.ref017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1099\/jgv.0.000328","article-title":"Adenovirus hexon modifications influence in vitro properties of pseudotyped human adenovirus type 5 vectors","volume":"97","author":"M Solanki","year":"2016","journal-title":"J Gen Virol"},{"issue":"7","key":"ppat.1010859.ref018","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/mt.2011.71","article-title":"Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer","volume":"19","author":"R Khare","year":"2011","journal-title":"Mol Ther"},{"issue":"12","key":"ppat.1010859.ref019","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"L Coughlan","year":"2012","journal-title":"Mol Ther"},{"issue":"8","key":"ppat.1010859.ref020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/CVI.00207-14","article-title":"Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors","volume":"21","author":"JE Teigler","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"571","key":"ppat.1010859.ref021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"S Atasheva","year":"2020","journal-title":"Sci Transl Med"},{"issue":"5304","key":"ppat.1010859.ref022","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"issue":"7","key":"ppat.1010859.ref023","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"RP Tomko","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ppat.1010859.ref024","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment","volume":"73","author":"TJ Wickham","year":"1993","journal-title":"Cell"},{"issue":"10","key":"ppat.1010859.ref025","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101641","article-title":"Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy","volume":"13","author":"M Romanenko","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"ppat.1010859.ref026","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.virol.2009.08.038","article-title":"Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents","volume":"394","author":"EV Shashkova","year":"2009","journal-title":"Virology"},{"issue":"3","key":"ppat.1010859.ref027","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1535-7163.MCT-21-0240","article-title":"Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo","volume":"21","author":"J Doerner","year":"2022","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"ppat.1010859.ref028","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00284-17","article-title":"Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5","volume":"91","author":"AE Tollefson","year":"2017","journal-title":"J Virol"},{"issue":"8","key":"ppat.1010859.ref029","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/104303403765255165","article-title":"Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice","volume":"14","author":"TA Smith","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"7","key":"ppat.1010859.ref030","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating antibodies and macrophages as modulators of adenovirus pharmacology","volume":"87","author":"R Khare","year":"2013","journal-title":"J Virol"},{"issue":"10","key":"ppat.1010859.ref031","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/JCM.00156-11","article-title":"Computational analysis of two species C human adenoviruses provides evidence of a novel virus","volume":"49","author":"MP Walsh","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"Pt 2","key":"ppat.1010859.ref032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1099\/vir.0.83057-0","article-title":"Evidence of frequent recombination among human adenoviruses","volume":"89","author":"AN Lukashev","year":"2008","journal-title":"J Gen Virol"},{"key":"ppat.1010859.ref033","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/OV.S155946","article-title":"Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer","volume":"7","author":"TV Nguyen","year":"2018","journal-title":"Oncolytic Virother"},{"issue":"1","key":"ppat.1010859.ref034","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-018-37249-4","article-title":"Molecular Evolution of Human Adenovirus (HAdV) Species C","volume":"9","author":"A Dhingra","year":"2019","journal-title":"Sci Rep."},{"key":"ppat.1010859.ref035","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","article-title":"Multiple Vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes in vitro and in vivo","volume":"108","author":"AL Parker","year":"2006","journal-title":"Blood"},{"issue":"8","key":"ppat.1010859.ref036","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/mt.2008.132","article-title":"Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver","volume":"16","author":"F Vigant","year":"2008","journal-title":"Mol Ther"},{"key":"ppat.1010859.ref037","article-title":"Coagulation Factor IX Mediates Serotype-Specific Binding of Species A Adenoviruses to Host Cells","author":"A Lenman","year":"2011","journal-title":"J Virol"},{"key":"ppat.1010859.ref038","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0083-6729(00)58031-5","article-title":"Vitamin K-dependent proteins","volume":"58","author":"GL Nelsestuen","year":"2000","journal-title":"Vitam Horm"},{"issue":"17","key":"ppat.1010859.ref039","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1128\/JVI.01070-13","article-title":"Coagulation factor binding orientation and dimerization may influence infectivity of adenovirus-coagulation factor complexes","volume":"87","author":"EE Irons","year":"2013","journal-title":"J Virol"},{"issue":"5447","key":"ppat.1010859.ref040","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","article-title":"Control of early viral and bacterial distribution and disease by natural antibodies","volume":"286","author":"AF Ochsenbein","year":"1999","journal-title":"Science"},{"issue":"4","key":"ppat.1010859.ref041","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2004.02.004","article-title":"Polyreactivity of antibody molecules","volume":"25","author":"AL Notkins","year":"2004","journal-title":"Trends Immunol"},{"issue":"2","key":"ppat.1010859.ref042","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2009.06.003","article-title":"IgM in microbial infections: taken for granted?","volume":"125","author":"R Racine","year":"2009","journal-title":"Immunol Lett"},{"key":"ppat.1010859.ref043","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-1-4939-7180-0_15","volume-title":"Natural antibodies: methods and protocols. Methods in Molecular Biology 1643","author":"Z Xu","year":"2017"},{"issue":"2","key":"ppat.1010859.ref044","doi-asserted-by":"crossref","first-page":"e0192353","DOI":"10.1371\/journal.pone.0192353","article-title":"Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum","volume":"13","author":"AW Harmon","year":"2018","journal-title":"PLoS One"},{"issue":"24","key":"ppat.1010859.ref045","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1073\/pnas.1901841116","article-title":"Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b","volume":"116","author":"TH Sharp","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ppat.1010859.ref046","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"J Chen","year":"1993","journal-title":"Int Immunol"},{"issue":"5","key":"ppat.1010859.ref047","first-page":"439","article-title":"Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications","volume":"10","author":"AL Parker","year":"2008","journal-title":"Curr Opin Mol Ther"},{"issue":"10","key":"ppat.1010859.ref048","doi-asserted-by":"crossref","first-page":"e1001142","DOI":"10.1371\/journal.ppat.1001142","article-title":"Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X","volume":"6","author":"AC Bradshaw","year":"2010","journal-title":"PLoS Pathog"},{"key":"ppat.1010859.ref049","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1128\/JVI.05382-11","article-title":"A cluster of basic amino acids in the factor X serine protease mediate surface attachment of adenovirus:FX complexes","volume":"85","author":"MR Duffy","year":"2011","journal-title":"J Virol"},{"issue":"3","key":"ppat.1010859.ref050","doi-asserted-by":"crossref","first-page":"e1006914","DOI":"10.1371\/journal.ppat.1006914","article-title":"Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor","volume":"14","author":"N Stichling","year":"2018","journal-title":"PLoS Pathog."},{"issue":"4","key":"ppat.1010859.ref051","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"R Khare","year":"2012","journal-title":"J Virol"},{"issue":"4","key":"ppat.1010859.ref052","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/hum.2013.222","article-title":"Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer","volume":"25","author":"S Sumarheni","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"15","key":"ppat.1010859.ref053","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2009-12-260026","article-title":"Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors","volume":"116","author":"R Alba","year":"2010","journal-title":"Blood"},{"issue":"3","key":"ppat.1010859.ref054","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jconrel.2012.05.025","article-title":"Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses","volume":"164","author":"AC Bradshaw","year":"2012","journal-title":"J Control Release"},{"issue":"9","key":"ppat.1010859.ref055","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood-2008-09-178459","article-title":"Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1","volume":"113","author":"RC Carlisle","year":"2009","journal-title":"Blood"},{"issue":"12","key":"ppat.1010859.ref056","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/cgt.2016.50","article-title":"Adenovirus coxsackie adenovirus receptor-mediated binding to human erythrocytes does not preclude systemic transduction","volume":"23","author":"LA Rojas","year":"2016","journal-title":"Cancer Gene Ther"},{"issue":"1\u20132","key":"ppat.1010859.ref057","first-page":"155","article-title":"Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector","volume":"81","author":"ZL Xu","year":"2002","journal-title":"J Control Release"},{"issue":"5","key":"ppat.1010859.ref058","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ymthe.2003.08.014","article-title":"Improved system for helper-dependent adenoviral vector production","volume":"8","author":"D Palmer","year":"2003","journal-title":"Mol Ther"},{"issue":"9","key":"ppat.1010859.ref059","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/sj.gt.3300995","article-title":"Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration","volume":"6","author":"R Parks","year":"1999","journal-title":"Gene Ther"},{"issue":"50","key":"ppat.1010859.ref060","doi-asserted-by":"crossref","first-page":"17361","DOI":"10.1021\/bi981177x","article-title":"Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein","volume":"37","author":"H Atoda","year":"1998","journal-title":"Biochemistry"},{"issue":"Pt C","key":"ppat.1010859.ref061","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0076-6879(81)80065-1","article-title":"Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone","volume":"80","author":"C Kettner","year":"1981","journal-title":"Methods Enzymol"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1010859","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:56:48Z","timestamp":1665079008000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1010859"}},"subtitle":[],"editor":[{"given":"Dmitry","family":"Shayakhmetov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":61,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1010859","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1010859","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]}}}